News & partners

Dianosic is a biotech focused on the development of novel solutions integrated drug and
delivery system for the localized treatment of patients with chronic rhinitis and chronic rhinosinusitis.

Latest news

All Awards Company Events Invest Partners
Oct 29, 2021

101 Best France Medical Device Startups

See more
Sep 24, 2021

Dianosic at the ERS congress 2021

See more
Jul 08, 2021

What are the main causes of epistaxis?

See more
Apr 19, 2021

Snitem – Dianosic receives the public’s favorite award 2021

See more
Mar 31, 2021

Challenges – Dianosic has been selected among the 100 most innovative startups to invest in 2021

See more

They support us

Our investors

We built a solid network of partners to support company funding and growth.

Fondation Force
Bpi France
Banque Populaire Rives de Paris
Caisse d’épargne Grand Est
Wiseed